SXTP

60 Degrees Pharmaceuticals, Inc. (SXTP) PESTLE Analysis Analysis (2026)

Invetso Score: 5.8/10 — Balanced · Last Updated: 2026-09-01

Monthly Update
Overall Score5.8 → 5.8
Change0

Political

Score: 5.8 (Moderate)

SXTP operates in politically stable jurisdictions and benefits from alignment with public health priorities, but its heavy reliance on regulatory decisions and potential exposure to shifting government focus present moderate political risk.

Economic

Score:

SXTP’s economic position is constrained by its small scale, ongoing losses, and reliance on future clinical and regulatory milestones to access larger markets. While revenue growth is notable, the company remains structurally weak compared to larger, profitable peers.

Social

Score:

SXTP’s focus on underserved diseases and patient engagement initiatives position it favorably in terms of social impact, but ultimate growth depends on successful product adoption and continued public health attention.

Technological

Score:

SXTP demonstrates technological strength through innovation and partnerships, but its platform is still early-stage and dependent on successful clinical outcomes to establish a durable competitive advantage.

Legal

Score:

SXTP faces moderate legal risk due to the complex regulatory environment and reliance on IP protection, but no material legal proceedings or compliance failures have been disclosed.

Environmental

Score:

SXTP’s environmental risk profile is moderate, with limited direct impact and positive contributions to public health, though it remains subject to standard industry regulations.

Overall Score

Score:

SXTP’s macro-environmental positioning is moderate across all PESTLE dimensions. The company benefits from political stability, social alignment with unmet medical needs, and technological innovation, but is constrained by small scale, persistent losses, regulatory dependence, and early-stage pipeline risk. Its future hinges on successful clinical outcomes, regulatory approvals, and the ability to scale commercially.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on 60 Degrees Pharmaceuticals, Inc.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →

Invetso is not affiliated with or regulated by the U.S. Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), or any other financial regulatory authority. The analyses, scores and all the information provided by Invetso are strictly for informational purposes only and do not constitute financial advice, recommendations, or an offer to buy or sell any securities. Invetso is not a registered financial advisor, broker-dealer, or investment advisor, and it does not provide personalized investment, legal, or tax advice. The content provided on this website is not intended to serve as a substitute for professional advice. Users should conduct their own research and consult with a qualified financial advisor before making any investment decisions. All analysis, data, and information presented on this site are based on publicly available information and should be used at the user’s own risk. Invetso does not guarantee the accuracy, completeness, or timeliness of any information or data provided, nor does it endorse any specific securities, companies, or strategies. Any reliance you place on such information is strictly at your own risk. While we strive to provide accurate and up-to-date information, Invetso makes no warranties or representations regarding the completeness, accuracy, or reliability of any analyses or data on our platform, and any such information is subject to the terms and conditions of the Invetso Terms of Service. Our analyses are generated using AI technologies and AI-generated content may contain errors or inaccuracies. Use the information at your own risk. Our platform may contain links to third-party websites, for which we are not responsible for the content or accuracy of information. Invetso shall not be liable for any loss or damage arising from the use of our services. By using this website, you agree that Invetso is not responsible for any losses, damages, or financial outcomes that may result from your use of the information, tools, or resources provided. We recommend consulting with a licensed financial professional before making any investment decisions.

For more details, please refer to our Terms of Service and Privacy Policy.